| RS1204647586 |
PLXNA1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurodevelopmental disorder, Dworschak-Punetha neurodevelopmental syndrome |
| RS1204653825 |
CCM2
|
Health Risk |
Likely pathogenic |
— |
| RS1204659204 |
OGT
|
Health Risk |
Likely pathogenic |
— |
| RS1204664319 |
BBS9
|
Health Risk |
Likely pathogenic |
Bardet-Biedl syndrome 9, Bardet-Biedl syndrome 9 |
| RS1204692060 |
DNAH11
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1204708376 |
G6PC1
|
Health Risk |
Pathogenic |
Glycogen storage disease due to glucose-6-phosphatase deficiency type IA, Glycogen storage disease due to glucose-6-phosphatase deficiency type IA |
| RS1204728357 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS1204728952 |
USH2A
|
Health Risk |
Likely pathogenic |
— |
| RS1204734473 |
MSH3
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1204741025 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS1204744283 |
LIPA
|
Health Risk |
Likely pathogenic |
Wolman disease, Cholesteryl ester storage disease |
| RS1204749077 |
PEPD
|
Health Risk |
Pathogenic |
Prolidase deficiency, Prolidase deficiency |
| RS1204749633 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Tuberous sclerosis 2 |
| RS1204763173 |
COL9A2
|
Health Risk |
Pathogenic |
— |
| RS1204764976 |
NPHP1
|
Health Risk |
Pathogenic |
Nephronophthisis, Nephronophthisis |
| RS1204766339 |
RAG2
|
Health Risk |
Conflicting classifications of pathogenicity |
Histiocytic medullary reticulosis, Combined immunodeficiency with skin granulomas |
| RS1204788520 |
MUSK
|
Health Risk |
Likely pathogenic |
Fetal akinesia deformation sequence 1, Congenital myasthenic syndrome 9 |
| RS1204814114 |
ABCD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Adrenoleukodystrophy, Inborn genetic diseases |
| RS1204830852 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS1204832680 |
KIF7
|
Health Risk |
Pathogenic |
Acrocallosal syndrome, Acrocallosal syndrome |
| RS1204835904 |
CYP11B2
|
Health Risk |
Pathogenic |
— |
| RS1204839587 |
DSP
|
Health Risk |
Conflicting classifications of pathogenicity |
Arrhythmogenic cardiomyopathy with wooly hair and keratoderma, Arrhythmogenic right ventricular dysplasia 8 |
| RS1204840140 |
AGL
|
Health Risk |
Pathogenic |
Glycogen storage disease type III, Glycogen storage disease |
| RS1204856744 |
IQSEC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, X-linked 1 |
| RS1204857679 |
ABCB4
|
Health Risk |
Likely pathogenic |
Cholestasis, intrahepatic |
| RS1204867394 |
SEPSECS
|
Health Risk |
Likely pathogenic |
— |
| RS1204868565 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS1204905333 |
RBM20
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1DD, Cardiovascular phenotype |
| RS1204909245 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS12049100 |
ADAMTSL4
|
Health Risk |
Conflicting classifications of pathogenicity |
Ectopia lentis 2, isolated |
| RS1204915217 |
SCN5A
|
Health Risk |
Pathogenic/Likely pathogenic |
Cardiovascular phenotype, Cardiac arrhythmia |
| RS1204924769 |
NPHP4
|
Health Risk |
Likely pathogenic |
Nephronophthisis 4, Senior-Loken syndrome 4 |
| RS1204972424 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS1204990361 |
BTD
|
Health Risk |
Pathogenic |
Biotinidase deficiency, Biotinidase deficiency |
| RS1205000981 |
MYH9
|
Health Risk |
Conflicting classifications of pathogenicity |
Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss, Autosomal dominant nonsyndromic hearing loss 17 |
| RS1205006300 |
FANCL
|
Health Risk |
Likely pathogenic |
Fanconi anemia, Fanconi anemia |
| RS1205019601 |
ITGB3
|
Health Risk |
Likely pathogenic |
Glanzmann thrombasthenia, Glanzmann thrombasthenia |
| RS1205026049 |
ALMS1
|
Health Risk |
Conflicting classifications of pathogenicity |
ALMS1-related disorder, Cardiovascular phenotype |
| RS1205027821 |
COL7A1
|
Health Risk |
Pathogenic |
Epidermolysis bullosa dystrophica, 7 conditions |
| RS1205029214 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial adenomatous polyposis 2, Hereditary cancer-predisposing syndrome |
| RS1205044520 |
MYH7
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy, Cardiomyopathy |
| RS1205047449 |
HJV
|
Health Risk |
Pathogenic |
Hemochromatosis type 2A, Hemochromatosis type 2A |
| RS1205051168 |
SLC25A20
|
Health Risk |
Conflicting classifications of pathogenicity |
Carnitine acylcarnitine translocase deficiency, Carnitine acylcarnitine translocase deficiency |
| RS1205064584 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS1205077486 |
DYSF
|
Health Risk |
Pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS1205111368 |
SLC29A3
|
Health Risk |
Pathogenic |
H syndrome, H syndrome |
| RS1205172165 |
POMT1
|
Health Risk |
Pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1 |
| RS1205189543 |
AHI1
|
Health Risk |
Conflicting classifications of pathogenicity |
Joubert syndrome, Joubert syndrome 3 |
| RS1205192306 |
CYP11B2
|
Health Risk |
Pathogenic |
Corticosterone methyl oxidase type II deficiency, Corticosterone methyl oxidase type II deficiency |
| RS1205259499 |
IFNAR2
|
Health Risk |
Pathogenic |
— |
| RS1205280922 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1205283728 |
MED13L
|
Health Risk |
Pathogenic |
— |
| RS1205301894 |
BLM
|
Health Risk |
Pathogenic/Likely pathogenic |
Bloom syndrome, Hereditary cancer-predisposing syndrome |
| RS1205322456 |
USH2A
|
Health Risk |
Likely pathogenic |
— |
| RS1205325321 |
INVS
|
Health Risk |
Pathogenic |
Nephronophthisis, Nephronophthisis |
| RS1205346910 |
VHL
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1205361096 |
FECH
|
Health Risk |
Likely pathogenic |
— |
| RS1205382497 |
RP1L1
|
Health Risk |
Pathogenic |
— |
| RS1205392044 |
MET
|
Health Risk |
Conflicting classifications of pathogenicity |
Renal cell carcinoma, Hereditary cancer-predisposing syndrome |
| RS1205403546 |
KIF1B
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS1205407134 |
ACADVL
|
Health Risk |
Likely pathogenic |
Very long chain acyl-CoA dehydrogenase deficiency, Very long chain acyl-CoA dehydrogenase deficiency |
| RS1205407936 |
TBC1D24
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 1 |
| RS1205409465 |
TTN
|
Health Risk |
Pathogenic/Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1205429003 |
SLC40A1
|
Health Risk |
Likely pathogenic |
Hemochromatosis type 4, Hemochromatosis type 4 |
| RS1205477836 |
UGT1A1
|
Health Risk |
Likely pathogenic |
— |
| RS1205480064 |
LDLR
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypercholesterolemia, familial |
| RS1205501595 |
TTN
|
Health Risk |
Pathogenic/Likely pathogenic |
Primary dilated cardiomyopathy, Cardiovascular phenotype |
| RS1205507761 |
GAA
|
Health Risk |
Pathogenic |
Glycogen storage disease, type II |
| RS1205517548 |
MAP2K2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiofaciocutaneous syndrome 4 |
| RS1205536026 |
TP63
|
Health Risk |
Pathogenic |
TP63-Related Spectrum Disorders, TP63-related disorder |
| RS1205552952 |
KCNQ1
|
Health Risk |
Likely pathogenic |
Cardiac arrhythmia, Cardiovascular phenotype |
| RS1205557903 |
TCOF1
|
Health Risk |
Likely pathogenic |
TCOF1-related disorder, TCOF1-related disorder |
| RS1205598688 |
CUBN
|
Health Risk |
Pathogenic |
Imerslund-Grasbeck syndrome type 1, Imerslund-Grasbeck syndrome type 1 |
| RS1205610948 |
DYNC2H1
|
Health Risk |
Pathogenic |
Jeune thoracic dystrophy, Jeune thoracic dystrophy |
| RS1205613982 |
VPS13B
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Cohen syndrome |
| RS1205637557 |
RAB3GAP1
|
Health Risk |
Pathogenic |
— |
| RS1205645084 |
NBAS
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive NBAS-related disorders, Autosomal recessive NBAS-related disorders |
| RS1205657950 |
PAH
|
Health Risk |
Likely pathogenic |
Phenylketonuria, Phenylketonuria |
| RS1205668341 |
BAP1
|
Health Risk |
Pathogenic/Likely pathogenic |
BAP1-related tumor predisposition syndrome, Hereditary cancer-predisposing syndrome |
| RS1205685022 |
MSR1
|
Health Risk |
Likely pathogenic |
Ovarian cancer, Ovarian cancer |
| RS1205686109 |
NAXE
|
Health Risk |
Likely pathogenic |
Encephalopathy, progressive |
| RS1205704532 |
ALMS1
|
Health Risk |
Pathogenic |
Retinal dystrophy, Alstrom syndrome |
| RS1205712508 |
SLC26A4
|
Health Risk |
Pathogenic/Likely pathogenic |
Pendred syndrome, Autosomal recessive nonsyndromic hearing loss 4 |
| RS1205746953 |
NF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Cardiovascular phenotype |
| RS1205748381 |
AHCY
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Hypermethioninemia with deficiency of S-adenosylhomocysteine hydrolase |
| RS1205756499 |
CREBBP
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Rubinstein-Taybi syndrome |
| RS1205776232 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS1205781478 |
ARSB
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis type 6, Mucopolysaccharidosis type 6 |
| RS1205782054 |
HERC1
|
Health Risk |
Pathogenic |
— |
| RS1205783002 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS1205793780 |
IKBKB
|
Health Risk |
Pathogenic |
Severe combined immunodeficiency due to IKK2 deficiency, Severe combined immunodeficiency due to IKK2 deficiency |
| RS1205797949 |
MYT1L
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 39 |
| RS1205803331 |
EYS
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 25, Retinitis pigmentosa 25 |
| RS1205836993 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1205842358 |
MCPH1
|
Health Risk |
Pathogenic/Likely pathogenic |
Microcephaly 1, primary |
| RS1205847358 |
ANKRD26
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, ANKRD26-related disorder |
| RS1205866071 |
CACNA1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Episodic ataxia type 2, Developmental and epileptic encephalopathy |
| RS1205882839 |
MFN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2A2 |
| RS1205889080 |
TMPRSS3
|
Health Risk |
Pathogenic |
— |
| RS1205890585 |
FHOD3
|
Health Risk |
Pathogenic/Likely pathogenic |
Cardiomyopathy, familial hypertrophic |